近期论文
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
Wang L, Liu Y, Yu G. Avasimibe inhibits tumor growth by targeting FoxM1-AKR1C1 in osteosarcoma. Onco Targets Ther. 2019 Jan 24;12:815-823. 通讯作者
Jin GZ, Zhang Y, Cong WM, Wu X, Wang X, Wu S, Wang S, Zhou W, Yuan S, Gao H, Yu G, Yang W. Phosphoglucomutase 1 inhibits hepatocellular carcinoma progression by regulating glucose trafficking. PLoS Biol. 2018 Oct 18;16(10):e2006483. 共同通讯作者
Zhang J, Liu X, Yu G, Liu L, Wang J, Chen X, Bian Y, Ji Y, Zhou X, Chen Y, Ji J, Xiang Z, Guo L, Fang J, Sun Y, Cao H, Zhu Z, Yu Y.UBE2C Is a Potential Biomarker of Intestinal-Type Gastric Cancer With Chromosomal Instability. Front Pharmacol. 2018 Aug 2;9:847. 共同第一作者
Zhang Y, Yu G, Chu H, Wang X, Xiong L, Cai G, Liu R, Gao H, Tao B, Li W, Li G, Liang J, Yang W. Macrophage-Associated PGK1 Phosphorylation Promotes Aerobic Glycolysis and Tumorigenesis. Mol Cell. 2018 Jul 19;71(2):201-215.e7. 共同第一作者
Liang Q, Nan Y, Coppola G, Zou K, Sun W, Zhang D, Wang Y, Yu G. Weakly Supervised Biomedical Image Segmentation by Reiterative Learning. IEEE J Biomed Health Inform. 2019 May;23(3):1205-1214. doi: 10.1109/JBHI.2018.2850040. Epub 2018 Jun 25. 通讯作者
Jiao X, Yu W, Qian J, Chen Y, Wei P, Fang W, Yu G. ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1. BMC Cancer. 2018 May 18;18(1):570. doi: 10.1186/s12885-018-4294-9. 通讯作者
Xu D, Miao Y, Gu X, Wang J, Yu G. Pyrophosphatase 1 expression is associated with future recurrence and overall survival in Chinese patients with intrahepatic cholangiocarcinoma. Oncol Lett. 2018 May;15(5):8095-8101. 通讯作者
Jiao XD, Ding C, Zang YS, Yu G. Rapid symptomatic relief of HER2-positive gastric cancer leptomeningeal carcinomatosis with lapatinib, trastuzumab and capecitabine: a case report. BMC Cancer. 2018 Feb 20;18(1):206. 通讯作者
Fang W, Qian J, Wu Q, Chen Y, Yu G. ADAM-17 expression is enhanced by FoxM1 and is a poor prognostic sign in gastric carcinoma. J Surg Res. 2017 Dec;220:223-233. 通讯作者
Chen Y, Li Y, Xue J, Gong A, Yu G, Zhou A, Lin K, Zhang S, Zhang N, Gottardi CJ, Huang S. Wnt-induced deubiquitination FoxM1 ensures nucleus β-catenin transactivation. EMBO J. 2016 Mar 15;35(6):668-84. 参与作者
Yu G, Yu W, Jin G, Xu D, Chen Y, Xia T, Yu A, Fang W, Zhang X, Li Z, Xie K. PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma. Mol Cancer. 2015 Nov 14;14:193.
Yu G, Fang W, Xia T, Chen Y, Gao Y, Jiao X, Huang S, Wang J, Li Z, Xie K. Metformin potentiates rapamycin and cisplatin in gastric cancer in mice. Oncotarget. 2015 May 20;6(14):12748-62.
Chen Y, Xiang H, Zhang Y, Wang J, Yu G. Loss of PCDH9 is associated with the differentiation of tumor cells and metastasis and predicts poor survival in gastric cancer. Clin Exp Metastasis. 2015 Jun;32(5):417-28. 通讯作者
Sun A, Yu G, Dou X, Yan X, Yang W, Lin Q. Nedd4-1 is an exceptional prognostic biomarker for gastric cardia adenocarcinoma and functionally associated with metastasis. Mol Cancer. 2014 Nov 14;13:248. 共同第一作者
Xu D, Yi W, Chen Y, Ma L, Wang J, Yu G. Overexpression of Sig1R is closely associated with tumor progression and poor outcome in patients with hilar cholangiocarcinoma. Med Oncol. 2014 Dec;31(12):261. 通讯作者
Gao Y, Chen Y, Xu D, Wang J, Yu G. Differential expression of ANXA1 in benign human gastrointestinal tissues and cancers. BMC Cancer. 2014 Jul 19;14:520. 通讯作者
Fang W, Cui H, Yu D, Chen Y, Wang J, Yu G. Increased expression of phospho-acetyl-CoA carboxylase protein is an independent prognostic factor for human gastric cancer without lymph node metastasis. Med Oncol. 2014 Jul;31(7):15. 通讯作者
Xue J, Lin X, Chiu WT, Chen YH, Yu G, Liu M, Feng XH, Sawaya R, Medema RH, Hung MC, Huang S. Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasis. J Clin Invest. 2014 Feb;124(2):564-79. 参与作者
Wang K, Cao F, Fang W, Hu Y, Chen Y, Ding H, Yu G. Activation of SNAT1/SLC38A1 in human breast cancer: correlation with p-Akt overexpression.BMC Cancer. 2013 Jul 12;13:343. 通讯作者
Liu K, Wang G, Ding H, Chen Y, Yu G, Wang J. Downregulation of metastasis suppressor 1(MTSS1) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancer. BMC Cancer. 2010 Aug 15;10:428. 通讯作者
Chen Y, Yu G, Yu D, Zhu M. PKCalpha-induced drug resistance in pancreatic cancer cells is associated with transforming growth factor-beta1. J Exp Clin Cancer Res. 2010 Aug 5;29:104. 共同第一作者
Yu WL, Cong WM, Zhang Y, Chen Y, Wang F, Yu G. Overexpression of ATA1/SLC38A1 predicts future recurrence and death in Chinese patients with hilar cholangiocarcinoma. J Surg Res. 2011 Dec;171(2):663-8. 通讯作者
Yu GZ, Chen Y, Wang JJ. Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance. J Cancer Res Clin Oncol. 2009 Oct;135(10):1331-9.第一作者
Yu G, Gao Y, Ni C, Chen Y, Pan J, Wang X, Ding Z, Wang J. Reduced expression of EphB2 is significantly associated with nodal metastasis in Chinese patients with gastric cancer. J Cancer Res Clin Oncol. 2011 Jan;137(1):73-80.第一作者
Yu G, Wang J, Chen Y, Wang X, Pan J, Li G, Jia Z, Li Q, Yao JC, Xie K. Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of chinese patients with gastric cancer. Clin Cancer Res. 2009 Mar 1;15(5):1821-9.
Yu G, Wang J, Chen Y, Wang X, Pan J, Li Q, Xie K. Tissue microarray analysis reveals strong clinical evidence for a close association between loss of annexin A1 expression and nodal metastasis in gastric cancer. Clin Exp Metastasis. 2008;25(7):695-702.
Yu G, Zhu MH, Zhu Z, Ni CR, Zheng JM, Li FM. Expression of ATM protein and its relationship with p53 in pancreatic carcinoma with tissue array. Pancreas. 2004 May;28(4):421-6. 第一作者
Liang Q, Nan Y, Coppola G, Zou K, Sun W, Zhang D, Yu G(corresponding). Weakly-supervised biomedical image segmentation by reiterative learning. IEEE J Biomed Health Inform. 2018 Jun 25. doi: 10.1109/JBHI.2018.2850040. IF=3.85
于观贞（通讯作者），刘西洋，张彦春，杨晶东，田建辉，朱明华. 人工智能在临床医学和科研转化中的应用和思考. 第二军医大学学报，2018，39（4）：359-366.
于观贞（通讯作者），魏培莲，陈颖，朱明华. 人工智能在肿瘤病理诊断和评估中的应用和思考. 第二军医大学学报，2017，38（1）：1349-1354.
高云姝,周洁,潘军,于观贞,梁军.人工智能技术在肺部肿瘤中的研究现状和应用前景.第二军医大学学报，2018.39(8):834-839.
陈辛畋,阮春阳,于观贞,张彦春.融“古”贯“今”,构建智慧中医新体系. 第二军医大学学报，2018.39(8):826-829.
陈颖,魏培莲,潘军,周洁,董昌盛,于观贞（通讯作者）.数字化全玻片助力人工智能病理图像决策. 第二军医大学学报，2018.39(8):840-845
杨蕴,阮春阳,杨美清,于观贞,田建辉.人工智能技术促进中医药传承发展. 第二军医大学学报，2018.39(8):873-877.
郑欣,周梅,孙力,邱崧,于观贞,李庆利.基于神经网络的显微高光谱乳腺癌组织图像研究. 第二军医大学学报，2018.39(8):886-891.
梁桥康,南洋,项韶,梅丽,孙炜,于观贞（通讯作者）.深度学习图像分割算法在胃癌病理切片中的可行性分析.第二军医大学学报，2018.39(8):903-908.
王斐,魏培莲,潘军,武清,于观贞（通讯作者）.人工智能技术在组织和细胞形态学评估中的应用. 第二军医大学学报，2018.39(8):923-927
唐仕超,于观贞,姜磊.人工智能技术在基于电子病历研究中的应用与展望. 第二军医大学学报，2018.39(8):928-934
张菁,徐家华,施莉,魏培莲,于观贞（通讯作者）.人工智能技术在护理领域的应用现状与发展趋势.第二军医大学学报，2018.39(8):939-封三.
京公网安备 11010802027423号